Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Carbone

Showing results (31-40 of 266) with videos related to

Pageof 27
Sort By:
Current Drug Targets|November 11, 2014
The role of adipocytokines in atherogenesis and atheroprogressionFederico Carbone, Francois Mach, Fabrizio Montecucco
European Heart Journal|February 10, 2024
The obesity syndemic in the European community: towards a systems thinking approach for preventive policiesGema Frühbeck, Luca Busetto, Federico Carbone
European Journal of Clinical Investigation|November 21, 2018
New insights into the role of DNA methylation in cardiovascular diseaseNicholas Bardi, Federico Carbone, Fabrizio Montecucco
European Journal of Clinical Investigation|November 14, 2017
A critical role of pentraxin 3 in severe sepsis and septic shockFederico Carbone, Fabrizio Montecucco, Fabio Rigamonti
European Journal of Clinical Investigation|December 1, 2020
Updating concepts on atherosclerotic inflammation: From pathophysiology to treatmentStefano Ministrini, Federico Carbone, Fabrizio Montecucco
Biomarkers in Medicine|October 11, 2019
Novel cardiovascular risk biomarkers in metabolic syndromeFabrizio Montecucco, Luca Liberale, Federico Carbone
Current Drug Targets|April 11, 2015
Editorial: update on inflammatory targets modulating atherogenesisFederico Carbone, François Mach, Fabrizio Montecucco
Advances in Experimental Medicine and Biology|April 16, 2021
Pharmacological Properties of the Plant-Derived Natural products Cannabinoids and Implications for Cardiovascular HealthLuca Liberale, Fabrizio Montecucco, Federico Carbone
European Journal of Clinical Investigation|March 29, 2024
CAR T therapy from haematological malignancies to aging-related diseases: An ever-expanding universeDavide Ramoni, Fabrizio Montecucco, Federico Carbone
Current Drug Targets|November 11, 2014
Update on the role of neutrophils in atherosclerotic plaque vulnerabilityFederico Carbone, Francois Mach, Fabrizio Montecucco
Pageof 27

Showing results (31-40 of 266) with videos related to

Sort By:
Pageof 27
Current Drug Targets|November 11, 2014
The role of adipocytokines in atherogenesis and atheroprogressionFederico Carbone, Francois Mach, Fabrizio Montecucco
European Heart Journal|February 10, 2024
The obesity syndemic in the European community: towards a systems thinking approach for preventive policiesGema Frühbeck, Luca Busetto, Federico Carbone
European Journal of Clinical Investigation|November 21, 2018
New insights into the role of DNA methylation in cardiovascular diseaseNicholas Bardi, Federico Carbone, Fabrizio Montecucco
European Journal of Clinical Investigation|November 14, 2017
A critical role of pentraxin 3 in severe sepsis and septic shockFederico Carbone, Fabrizio Montecucco, Fabio Rigamonti
European Journal of Clinical Investigation|December 1, 2020
Updating concepts on atherosclerotic inflammation: From pathophysiology to treatmentStefano Ministrini, Federico Carbone, Fabrizio Montecucco
Biomarkers in Medicine|October 11, 2019
Novel cardiovascular risk biomarkers in metabolic syndromeFabrizio Montecucco, Luca Liberale, Federico Carbone
Current Drug Targets|April 11, 2015
Editorial: update on inflammatory targets modulating atherogenesisFederico Carbone, François Mach, Fabrizio Montecucco
Advances in Experimental Medicine and Biology|April 16, 2021
Pharmacological Properties of the Plant-Derived Natural products Cannabinoids and Implications for Cardiovascular HealthLuca Liberale, Fabrizio Montecucco, Federico Carbone
European Journal of Clinical Investigation|March 29, 2024
CAR T therapy from haematological malignancies to aging-related diseases: An ever-expanding universeDavide Ramoni, Fabrizio Montecucco, Federico Carbone
Current Drug Targets|November 11, 2014
Update on the role of neutrophils in atherosclerotic plaque vulnerabilityFederico Carbone, Francois Mach, Fabrizio Montecucco
Pageof 27